HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duke-Cohan, J. S. Articles by Schlossman, S. F. Search for Related Content PubMed PubMed Citation Articles by Duke-Cohan, J. S. Articles by Schlossman, S. F. Social Bookmarking                      What's this?

Volume 270, Number 23, Issue of June 9, pp. 14107-14114, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Jonathan S. Duke-Cohan , Chikao Morimoto , Joshua A. Rocker , Stuart F. Schlossman

Human CD26, a Type II membrane glycoprotein with intrinsic dipeptidylpeptidase IV (DPPIV) activity and ability to bind adenosine deaminase type I (ADA-1), is expressed on epithelial cells constitutively, but on T lymphocytes its expression is regulated. A soluble form of CD26/DPPIV has been described in plasma and related to immunological status, but it has been defined by the presence of DPPIV activity rather than by isolation. Using nondenaturing chromatographic techniques followed by nondenaturing native preparative electrophoresis, we obtained a homogeneous preparation of soluble serum DPPIV and compared it with a recombinant soluble CD26/DPPIV (rsCD26). We show that serum DPPIV is a monomer of 175 kDa in contrast to rsCD26 of 105-110 kDa, that it exists as a trimer, and that it is probably a serine proteinase. Deglycosylation removed N-linked sugar from both serum DPPIV and rsCD26; no O-linked glycosylation was observed, revealing a protein core of 130 kDa for serum DPPIV. The large serum form expresses functional DPPIV activity with substrate and inhibitor specificities and pH activity profile similar to those of rsCD26. Epitope analysis showed that monoclonal antibodies against five epitopes expressed by rsCD26 also bound, but more weakly, with serum DPPIV. Analysis of peptides after limiting proteolysis and N-terminal sequences reveals no homology with rsCD26 but some identity with other peptidases. Unlike rsCD26, the serum form does not bind ADA-1 and has no ADA-1 already associated with it. Similarly to rsCD26, serum DPPIV is a potent T cell costimulator. We conclude that the serum form of DPPIV is unique and is not a breakdown product of membrane CD26. The conservation of DPPIV activity and five epitopes specific to rsCD26 suggest, however, a significant structural similarity.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Wrenger, J. Faust, D. Friedrich, T. Hoffmann, R. Hartig, U. Lendeckel, T. Kahne, A. Thielitz, K. Neubert, and D. Reinhold Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function J. Leukoc. Biol., September 1, 2006; 80(3): 621 - 629. [Abstract] [Full Text] [PDF]

				E. P. Boonacker, E. A. Wierenga, H. H. Smits, and C. J.F. Van Noorden CD26/DPPIV Signal Transduction Function, but Not Proteolytic Activity, Is Directly Related to Its Expression Level on Human Th1 and Th2 Cell Lines as Detected with Living Cell Cytochemistry J. Histochem. Cytochem., September 1, 2002; 50(9): 1169 - 1177. [Abstract] [Full Text] [PDF]

				S. Lorey, J. Faust, C. Mrestani-Klaus, T. Kahne, S. Ansorge, K. Neubert, and F. Buhling Transcellular Proteolysis Demonstrated by Novel Cell Surface-associated Substrates of Dipeptidyl Peptidase IV (CD26) J. Biol. Chem., August 30, 2002; 277(36): 33170 - 33177. [Abstract] [Full Text] [PDF]

				J. Korosi, C. H.S. McIntosh, R. A. Pederson, H.-U. Demuth, J. F. Habener, R. Gingerich, J. M. Egan, D. Elahi, and G. S. Meneilly Effect of Aging and Diabetes on the Enteroinsular Axis J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2001; 56(9): M575 - 579. [Abstract] [Full Text] [PDF]

				L. Hansen, C. F. Deacon, C. Ørskov, and J. J. Holst Glucagon-Like Peptide-1-(7-36)Amide Is Transformed to Glucagon-Like Peptide-1-(9-36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine Endocrinology, November 1, 1999; 140(11): 5356 - 5363. [Abstract] [Full Text]

				J. S. Duke-Cohan, J. Gu, D. F. McLaughlin, Y. Xu, G. J. Freeman, and S. F. Schlossman Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions PNAS, September 15, 1998; 95(19): 11336 - 11341. [Abstract] [Full Text] [PDF]

				P. Ruiz, N. Zacharievich, and M. Shenkin Clin. Vaccine Immunol., May 1, 1998; 5(3): 362 - 368. [Abstract]

				M. L. Pineiro-Sanchez, L. A. Goldstein, J. Dodt, L. Howard, Y. Yeh, and W.-T. Chen Identification of the 170-kDa Melanoma Membrane-bound Gelatinase (Seprase) as a Serine Integral Membrane Protease J. Biol. Chem., March 21, 1997; 272(12): 7595 - 7601. [Abstract] [Full Text] [PDF]

				R. P. Pauly, F. Rosche, M. Wermann, C. H.S. McIntosh, R. A. Pederson, and H.-U. Demuth Investigation of Glucose-dependent Insulinotropic Polypeptide(1-42) and Glucagon-like Peptide-1-(7-36) Degradation in Vitro by Dipeptidyl Peptidase IV Using Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry. A NOVEL KINETIC APPROACH J. Biol. Chem., September 20, 1996; 271(38): 23222 - 23229. [Abstract] [Full Text] [PDF]